Literature DB >> 10518948

Intrabody construction and expression. II. A synthetic catalytic Fv fragment.

E C Ohage1, P Wirtz, J Barnikow, B Steipe.   

Abstract

In general, proteins with structural disulfides cannot be expressed in the reducing environment of the cellular cytoplasm. To overcome this folding problem, we have previously engineered stabilizing mutations, predicted from a consensus sequence analysis, into isolated immunoglobulin VL domains. Here we show that such domains can be used as a framework in the construction of a functional heterodimeric Fv fragment, which was expressed solubly, with high yield in the cytoplasm of Escherichia coli. This designed catalytic intrabody, obtained from grafting the combining site of the esterolytic antibody 17E8, is active in the oxidized and the reduced state. Its construction required no special features on the part of the immunoglobulin, no single-chain linker and introduced no non-natural sequence motifs. The potential to design intrabodies with the recognition sequences of arbitrary immunoglobulins opens novel opportunities for gene therapy, cell biology, metabolic engineering and antibody biotechnology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518948     DOI: 10.1006/jmbi.1999.3020

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  5 in total

1.  Intrabody construction and expression III: engineering hyperstable V(H) domains.

Authors:  P Wirtz; B Steipe
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  De novo production of diverse intracellular antibody libraries.

Authors:  Tomoyuki Tanaka; Grace T Y Chung; Alan Forster; M Natividad Lobato; Terence H Rabbitts
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

3.  Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsid.

Authors:  J Vellinga; J de Vrij; S Myhre; T Uil; P Martineau; L Lindholm; R C Hoeben
Journal:  Gene Ther       Date:  2007-02-01       Impact factor: 5.250

4.  Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation.

Authors:  Tomoyuki Tanaka; Terence H Rabbitts
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

5.  Complementarity determining regions and frameworks contribute to the disulfide bond independent folding of intrinsically stable scFv.

Authors:  Anna Gąciarz; Lloyd W Ruddock
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.